An Overview of Step Pedcare Is Presented
Current literature suggests that griseofulvin continues to be effective in most patients with Tinea capitis. Ketoconazole is no more effective than griseofulvin and causes more adverse events and drug interactions. Adamson (2001)
DRUG STEPS OVERVIEW
|
Safety and tolerability
|
Mild adverse effects are
Associated with grisesofulvin, Ketoconazole, terbinafine and itraconazole.
While ketoconazole as associated with adrenal insufficiency, myopathy and
urticaria in adults with treat Tinea capitis, none of these adverse
events were noted in the pediatric studies. Although clinically significant
drug interactions are common with Ketoconazole and itraconazole, their
prevalence was not apparent in the pediatric studies.
|
|
Effectiveness
|
Griseofulvin continues to be
effective as a first –line drug in many patients. Terbinafine and traconazole
may be used in unresponsive causes. Terbinafine and traconazole are effective
in pulse and traditional does. However strong comparative clinical trial data
supporting their use are scarce.
|
|
Price
|
Griseofulvin is the most costly
agent supported POEMs (patient- oriented evidence that matters e.g,
compliance rates and clinical cure, such as hair growth, decreased
inflammation, and relapse rated for treating Tinea capitis. Other
antifungal agents are less costly, however, strong clinical data are lacking
to support their use.
|
REFERENCES
Ajello, L.J.
(1974). Natural History of the dermatophytes and related fungi mycopathologia
at myaslogia apphcata, 53, 93 – 110.
Al- Doory, Y.J,
Kalter, S.S. (1967). The isolation of histoplasma disboisi and keratindphilic
fungi from soils of East Africa.
Anosike J.C,
Keke I.R, Uweazuoke J.C, Anozie J.C, Obiukwu C.E, Nwoke B.E.B, Amaijuoyi
O.U. (2005). Prevalence and distribution of ringworm infection
in primary school children in parts of Eastern, Nigeria. Journal of Appl. Sc. And Environ. Management.9 (3):21-25
Ayadi A, Borgi N,
Makni F.(1993).Prevalence of Superficial mycoses in an urban ecosystem in
sfax (Tunisia).Bull.Soc. pathol. Exotique. 86:188-9.
Baron E.J, Murray
P.R., jorgensen J.H, pfaller M.A,
Yalken R.H (2003) manual of
clinical microbiology. (8th
ed.) sm press, Washington. 1798
–1817 pp.
Egere, T. U,
Gugnani, H.G. (1980). Etiology of
dermatopphytosis in Eastern Nigeria. Mykosen, 23, 178-18.